{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699994766557312.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1053/j.ajkd.2006.10.015"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0272638606016143?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0272638606016143?httpAccept=text/plain"}}],"dc:title":[{"@value":"Unexpected Efficacy of Rituximab in Multirelapsing Minimal Change Nephrotic Syndrome in the Adult: First Case Report and Pathophysiological Considerations"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381699994766557312","@type":"Researcher","foaf:name":[{"@value":"Hélène François"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699994766557314","@type":"Researcher","foaf:name":[{"@value":"Eric Daugas"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699994766557313","@type":"Researcher","foaf:name":[{"@value":"Albert Bensman"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699994766557315","@type":"Researcher","foaf:name":[{"@value":"Pierre Ronco"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"02726386"},{"@type":"PISSN","@value":"http://id.crossref.org/issn/02726386"}],"prism:publicationName":[{"@value":"American Journal of Kidney Diseases"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2007-01","prism:volume":"49","prism:number":"1","prism:startingPage":"158","prism:endingPage":"161"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","https://www.elsevier.com/legal/tdmrep-license"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0272638606016143?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0272638606016143?httpAccept=text/plain"}],"createdAt":"2007-02-06","modifiedAt":"2025-10-03","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050294045370453760","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206446314240","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"1. Pathogenesis and Management of Minimal Change Nephrotic Syndrome"},{"@language":"ja","@value":"1．微小変化型ネフローゼ症候群"},{"@value":"微小変化型ネフローゼ症候群"},{"@language":"ja-Kana","@value":"ビショウ ヘンカガタ ネフローゼ ショウコウグン"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679316799872","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"小児特発性ネフローゼ症候群―新たな治療戦略と今後の課題―"},{"@language":"en","@value":"Idiopathic nephrotic syndrome in children: a new treatment strategy and future perspective"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679849728512","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Successful Use of Single-Dose Rituximab for the Maintenance of Remission in a Patient with Steroid-Resistant Nephrotic Syndrome"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679850340992","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Rituximab Treatment for Adult Patients with Focal Segmental Glomerulosclerosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681420499968","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"3. Aspect of Childhood Nephrotic Syndrome"},{"@language":"ja","@value":"3．小児期ネフローゼ症候群の特徴"},{"@value":"小児期ネフローゼ症候群の特徴"},{"@language":"ja-Kana","@value":"ショウニキ ネフローゼ ショウコウグン ノ トクチョウ"}]},{"@id":"https://cir.nii.ac.jp/crid/2050870367073795072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prevention of hepatitis B virus reactivation in immunosuppressive therapy or chemotherapy"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1053/j.ajkd.2006.10.015"},{"@type":"CROSSREF","@value":"10.1007/s10157-011-0464-7_references_DOI_F6MTuqOc02BO5KGATKyRuJRWH9I"},{"@type":"CROSSREF","@value":"10.1007/s00467-017-3746-9_references_DOI_F6MTuqOc02BO5KGATKyRuJRWH9I"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.51.6854_references_DOI_F6MTuqOc02BO5KGATKyRuJRWH9I"},{"@type":"CROSSREF","@value":"10.2169/naika.98.998_references_DOI_F6MTuqOc02BO5KGATKyRuJRWH9I"},{"@type":"CROSSREF","@value":"10.3165/jjpn.rv.2015.0002_references_DOI_F6MTuqOc02BO5KGATKyRuJRWH9I"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.48.2435_references_DOI_F6MTuqOc02BO5KGATKyRuJRWH9I"},{"@type":"CROSSREF","@value":"10.2169/naika.102.1105_references_DOI_F6MTuqOc02BO5KGATKyRuJRWH9I"}]}